Roche Holding Ltd (RHHBY)
Drug Manufacturers - General
Last updated: Nov 13, 2026 at 4:00 PM ET
Roche Holding Ltd (RHHBY) Financials: Revenue, Profit and Cash Flow
Roche Holding reported revenue of CHF 63.36B for the fiscal year ended Dec 31, 2025, up 1.5% from the year before. That year, net income was CHF 12.88B with a net margin of 20.3%, operating cash flow was CHF 17.03B and free cash flow was CHF 13.45B. The quarter ended Dec 31, 2025 had revenue of CHF 30.32B and net income of CHF 5.42B.
Revenue and Margins
The operating margin was 29.2% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from CHF 59.50B, a compound annual rate of 0.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 63.36B | +1.5% | 73.7% | 29.2% | 20.3% |
| Dec 2024 | 62.40B | +3.2% | 73.9% | 21.5% | 13.3% |
| Dec 2023 | 60.44B | -8.2% | 74.2% | 25.5% | 19.0% |
| Dec 2022 | 65.81B | +4.8% | 72.7% | 26.6% | 18.9% |
| Dec 2021 | 62.80B | +7.7% | 68.6% | 27.5% | 22.2% |
| Dec 2020 | 58.32B | -8.5% | 72.0% | 31.8% | 24.5% |
| Dec 2019 | 63.75B | +7.1% | 72.7% | 33.0% | 21.2% |
| Dec 2018 | 59.50B | N/A | 72.2% | 31.8% | 17.6% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 55.6% from the year before. In the quarter ended Dec 2025, net income rose 168.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 63.36B | 62.40B | 60.44B | 65.81B | 62.80B | 58.32B | 63.75B | 59.50B |
| Cost of revenue | 16.64B | 16.28B | 15.60B | 17.94B | 19.70B | 16.35B | 17.39B | 16.52B |
| Gross profit | 46.71B | 46.11B | 44.84B | 47.88B | 43.10B | 41.97B | 46.37B | 42.98B |
| Research and development | 12.75B | 15.30B | 14.20B | 15.22B | 14.80B | 13.01B | 12.77B | 12.09B |
| Operating income | 18.48B | 13.42B | 15.39B | 17.48B | 17.28B | 18.54B | 21.03B | 18.92B |
| Net income | 12.88B | 8.28B | 11.50B | 12.42B | 13.93B | 14.29B | 13.50B | 10.50B |
| EBITDA | 21.70B | 16.62B | 18.41B | 24.07B | 22.19B | 22.97B | 25.34B | N/A |
Quarterly
| Line item | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | Jun 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30.32B | 15.92B | 31.64B | 30.76B | 30.66B | 29.78B | 30.99B | 32.30B | 32.09B | 30.71B | 29.04B | 29.28B |
| Gross profit | 21.75B | 12.05B | 22.83B | 23.28B | 20.66B | 22.24B | 21.90B | 22.55B | 21.62B | 21.47B | 20.59B | 21.37B |
| Operating income | 7.05B | 5.17B | 4.35B | 9.07B | 5.94B | 9.46B | 7.90B | 10.27B | 8.05B | 9.23B | 7.88B | 9.84B |
| Net income | 5.42B | 3.71B | 2.02B | 6.26B | 4.36B | 7.14B | 3.89B | 8.53B | 6.13B | 7.80B | 6.22B | 8.08B |
Balance Sheet
As of Dec 2025, total debt of CHF 31.67B exceeded cash and equivalents by 26.08B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 100.82B | 101.80B | 90.47B | 88.15B | 92.32B | 86.14B | 83.09B | 78.52B |
| Current assets | 38.77B | 40.04B | 33.45B | 33.82B | 35.63B | 32.94B | 31.25B | 32.24B |
| Cash and equivalents | 5.59B | 6.97B | 5.38B | 4.99B | 6.85B | 5.73B | 6.08B | 6.68B |
| Total liabilities | 62.89B | 65.64B | 57.20B | 56.14B | 63.97B | 46.37B | 47.22B | 48.15B |
| Short-term debt | 4.21B | 3.93B | 4.40B | 3.96B | 15.12B | 4.00B | 1.70B | 2.69B |
| Long-term debt | 27.46B | 30.72B | 24.81B | 21.39B | 16.08B | 10.22B | 12.67B | 16.08B |
| Shareholder equity | 33.84B | 31.77B | 29.32B | 27.99B | 24.49B | 36.34B | 32.75B | 27.62B |
Quarterly
| Line item | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | Jun 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 100.82B | 94.77B | 101.80B | 95.79B | 90.47B | 84.37B | 88.15B | 86.74B | 92.32B | 87.89B | 86.14B | 80.36B |
| Total liabilities | 62.89B | 61.72B | 65.64B | 62.91B | 57.20B | 54.03B | 56.14B | 57.79B | 63.97B | 46.45B | 46.37B | 45.55B |
| Cash and equivalents | 5.59B | 7.55B | 6.97B | 4.82B | 5.38B | 3.72B | 4.99B | 4.32B | 6.85B | 5.00B | 5.73B | 3.77B |
| Shareholder equity | 33.84B | 28.68B | 31.77B | 28.94B | 29.32B | 26.52B | 27.99B | 25.19B | 24.49B | 37.81B | 36.34B | 31.51B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 79.0% of operating cash flow. Dividends and share repurchases together came to 66.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 17.03B | 20.09B | 16.09B | 17.89B | 20.57B | 18.16B | 22.39B | 19.98B |
| Capital expenditures | 3.58B | 5.01B | 4.65B | 4.55B | 4.55B | 6.69B | 3.50B | 4.04B |
| Free cash flow | 13.45B | 15.09B | 11.45B | 13.34B | 16.02B | 11.47B | 18.88B | 15.94B |
| Dividends paid | 8.01B | 7.65B | 7.59B | 7.45B | 7.77B | 7.70B | 7.45B | 7.25B |
| Share repurchases | 942.63M | 1.13B | 1.14B | 1.26B | 18.99B | 2.13B | 947.00M | 448.00M |
| Investing cash flow | -8.32B | -11.39B | -10.64B | -3.57B | -6.55B | -9.08B | -8.63B | -7.20B |
| Financing cash flow | -9.72B | -6.82B | -4.24B | -15.72B | -12.70B | -9.24B | -14.17B | -10.69B |
Quarterly
| Line item | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 11.61B | 6.12B | 11.68B | 7.91B | 7.91B | 7.59B | 8.61B |
| Capital expenditures | 2.17B | 1.56B | 1.80B | 1.72B | 2.67B | 1.97B | 2.53B |
| Free cash flow | 9.44B | 4.56B | 9.88B | 6.19B | 5.23B | 5.61B | 6.08B |
Frequently Asked Questions About RHHBY
What is Roche Holding's annual revenue?
Roche Holding reported revenue of CHF 63.36B for the fiscal year ended Dec 31, 2025.
How fast is Roche Holding's revenue growing?
Revenue was up 1.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.3%.
Is Roche Holding profitable?
Yes. Roche Holding reported net income of CHF 12.88B for the fiscal year ended Dec 31, 2025, with a net margin of 20.3%.
How much free cash flow does RHHBY generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of CHF 17.03B minus capital expenditures of CHF 3.58B produced free cash flow of CHF 13.45B.
How much debt does Roche Holding have?
The balance sheet dated Dec 31, 2025 reported long-term debt of CHF 27.46B, short-term debt of CHF 4.21B and cash and equivalents of CHF 5.59B.
RHHBY pages: Overview, Dividends, Financials